[Reflections on prednisone therapy of patients with liver diseases].
D001663:Bilirubin / Q000032:analysis; D002908:Chronic Disease; D003864:Depression, Chemical; D005943:Gluconeogenesis / Q000187:drug effects; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006505:Hepatitis / Q000097:blood / Q000188:drug therapy; D006506:Hepatitis A / Q000188:drug therapy; D006801:Humans; D008099:Liver / Q000187:drug effects; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D008112:Liver Glycogen / Q000032:analysis; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use*; D013268:Stimulation, Chemical
D008112:Liver Glycogen; D001663:Bilirubin; D011241:Prednisone
Betrachtungen zur Prednisonbehandlung Leberkranker.